Crossmark

Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)

Crossref DOI link: https://doi.org/10.1007/s00520-022-06874-1

Published Online: 2022-02-03

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kikuchi, Katsuko

Yamazaki, Naoya

Nozawa, Keiko

Fukuda, Haruhiko

Shibata, Taro

Machida, Ryunosuke

Hamaguchi, Tetsuya

Takashima, Atsuo

Shoji, Hirokazu

Boku, Narikazu

Takatsuka, Sumiko

Takenouchi, Tatsuya

Nishina, Tomohiro

Yoshikawa, Shusuke

Takahashi, Masanobu

Hasegawa, Akiko

Kawazoe, Akihito

Masuishi, Toshiki

Mizutani, Hitoshi

Kiyohara, Yoshio
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP17ck0106326)
License Information

Text and Data Mining valid from 2022-02-03

Version of Record valid from 2022-02-03
More Information

Article History

Received: 13 August 2021

Accepted: 27 January 2022

First Online: 3 February 2022

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics review board of each participating institution. Research ethics boards at all participating institutions approved the study protocol.

: Each enrolled patient provided written informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below